By using this site, you agree to the Privacy Policy and Terms of Use.
Accept

Parami News

  • Home
  • Politics
  • India
  • World
  • Business
  • Entertainment
  • Regional
  • Sports
  • Web Stories
Search
© 2024 Parami News. All Rights Reserved.
Reading: Indian researchers working towards developing effective vaccine strategies against SARS-CoV-2 and HIV
Share
Sign In
Notification Show More
Font ResizerAa

Parami News

Font ResizerAa
Search
  • Home
  • Politics
  • India
  • World
  • Business
  • Entertainment
  • Regional
  • Sports
  • Web Stories
Have an existing account? Sign In
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Parami News > Blog > India > Indian researchers working towards developing effective vaccine strategies against SARS-CoV-2 and HIV
India

Indian researchers working towards developing effective vaccine strategies against SARS-CoV-2 and HIV

Atulya Shivam Pandey
Last updated: September 12, 2021 12:13 pm
Atulya Shivam Pandey
Share
6 Min Read
Indian researchers working towards developing effective vaccine strategies against SARS-CoV-2 and HIV
SHARE

Bengaluru: Indian Institute of Science claimed on Tuesday that researchers led by Raghavan Varadarajan, Professor at IISc’s Molecular Biophysics Unit, are working towards developing effective vaccine strategies against two viruses: SARS-CoV-2 and HIV.

In two studies published in the past week, they reported the design of a ‘heat-tolerant’ COVID-19 vaccine candidate and a rapid method to identify specific regions on the HIV envelopeprotein that are targeted by antibodies, which can help design effective vaccines, an IISc press release said.

The studies were published in the Journal of Biological Chemistry and the Proceedings of the National Academy of Sciences respectively, according to Bengaluru-based IISc.

The COVID-19 vaccine candidate contains a part of the spike protein of the novel coronavirus called the Receptor Binding Domain (RBD) – the region that helps the virus stick to the hosts cell.

It is being developed by Varadarajans lab in collaboration with Mynvax, a startup co-founded by him and incubated at IISc, as well as several other institutes.

“When tested in guinea pig models, the vaccine candidate triggered a strong immune response”, the statement said.

“Surprisingly, it also remained stable for a month at 37C, and freeze-dried versions could tolerate temperatures as high as 100C.

Such ‘warm’ vaccines can be stored and transported without expensive cooling equipment to remote areas for mass vaccination – most vaccines need to be stored between 2-8C or even cooler temperatures to avoid losing their potency”, it said.

Compared to newer types such as mRNA vaccines, making a protein-based vaccine like this can also be scaled up easily in India where manufacturers have been making similar vaccines for decades, IISc said.

There is another difference between the vaccine candidate being developed by Varadarajans team and many other COVID-19 vaccines in the works: it only uses a specific part of the RBD, a string of 200 amino acids, instead of the entire spike protein.

The team inserted genes coding for this part via a carrier DNA molecule called a plasmid, into mammalian cells, which then churned out copies of the RBD section.

They found that the RBD formulation was just as good as the full spike protein in triggering an immune response in guinea pigs, but much more stable at high temperatures for extended periods – the full spike protein quickly lost its activity at temperatures above 50C, according to the statement.

“Now we have to get funds to take this forward to clinical development, says Varadarajan.

This would include safety and toxicity studies in rats along with process development and GMP manufacture of a clinical trial batch, before they are tested in humans.

“Those studies can cost about Rs 10 crore. Unless the government funds us, we might not be able to take it forward”, he added.

The second study focused on HIV, the virus that causes AIDS, a disease for which there is no vaccine despite decades of research.

The team, which included researchers from multiple institutes, sought to pinpoint which parts of the HIVs envelope protein are targeted by neutralising antibodies – the ones that actually block virus entry into cells, not just flag it for other immune cells to find.

According to the authors, vaccines based on these regions might induce a better immune response. To map such regions, researchers use methods like X-ray crystallography and cryo- electron microscopy, but these are time-consuming, complicated and expensive.

Therefore, Varadarajan and his team explored alternative approaches, and eventually arrived at a simpler, yet effective solution.

First, they mutated the virus so that an amino acid called cysteine would pop up in several places on the envelope protein. They then added a chemical label that would stick to these cysteine molecules, and finally, treated the virus with neutralising antibodies.

If the antibodies could not bind to crucial sites on the virus because they were blocked by the cysteine label, the virus could survive and cause infection.

Those sites were then identified by sequencing the genes of the surviving mutant viruses.

“This is a rapid way of figuring out where antibodies are binding and is useful for vaccine design,” says Varadarajan.

It could also help in simultaneously testing how different peoples sera samples – the portions of their blood containing antibodies – react to the same vaccine candidate or virus, he says.

“In principle, researchers could adapt this methodology to any virus, including SARS-CoV-2”, he said. (PTI)

You Might Also Like

Graduation ceremony held for university colleges of engineering students

Staff of A.P. Raj Bhavan participate in Sankranthi celebrations

Two dozen workers trapped in Kannauj railway station building collapse

Bihar’s first sports university gets UGC recognition

Singer P. Jayachandran cremated with State honours in Chendamangalam

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article China successfully launches 13 satellites, including 10 for Argentina, with a single rocket China successfully launches 13 satellites, including 10 for Argentina, with a single rocket
Next Article First images of final design of Abu Dhabi’s first Hindu temple released First images of final design of Abu Dhabi’s first Hindu temple released
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

235.3kFollowersLike
69.1kFollowersFollow
11.6kFollowersPin
56.4kFollowersFollow
136kSubscribersSubscribe
4.4kFollowersFollow

Latest News

Harry Meghan LA Fire Victims: Major outrage over Harry-Meghan’s visit to LA fire victims: ‘You are not royals…merely two nitwit celebrities’
Harry Meghan LA Fire Victims: Major outrage over Harry-Meghan’s visit to LA fire victims: ‘You are not royals…merely two nitwit celebrities’
World January 11, 2025
‘My chapter is over’: Bangladesh veteran Tamim Iqbal retires from international cricket | Cricket News
‘My chapter is over’: Bangladesh veteran Tamim Iqbal retires from international cricket | Cricket News
Sports January 11, 2025
Pakistan anti-terrorism court grants bail to more than 150 workers of Imran Khan’s party

 | Parami News
Pakistan anti-terrorism court grants bail to more than 150 workers of Imran Khan’s party | Parami News
Most Recent Stories January 11, 2025
Virat Kohli and Rohit Sharma will find form again, says England pacer Tymal Mills | Cricket News
Virat Kohli and Rohit Sharma will find form again, says England pacer Tymal Mills | Cricket News
Sports January 11, 2025
//

We influence 20 million users and is the number one business and technology news network on the planet

Quick Link

  • About Us
  • Contact Us
  • Advertise With Us
  • DNPA Code of Ethics
  • Disclaimer
  • Privacy Policy

Top Categories

  • Business
  • Entertainment
  • India
  • Politics
  • Regional
  • Sports

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Follow US
© 2024 Parami News. All Rights Reserved.
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Welcome Back!

Sign in to your account

Lost your password?